SEC Form 4 · accession 0001012975-18-000222
Motus GI Holdings, Inc. · MOTS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Feb 16, 2018
Accepted (ET)
Feb 21, 2018 · 8:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001686850
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (right to buy)F1,F2 | $5.00 | Feb 16, 2018 | J | 180,055 | A | Aug 15, 2018 | Feb 16, 2023 | Common Stock | 180,055 | 180,055 | I |
Explanation of responses
- F1The securities were acquired as consideration for entering into one or more agreements in connection with the Issuer's initial public offering.
- F2The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.